🇺🇸 IV antibiotic in United States

14 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaemia — 2 reports (14.29%)
  2. Fall — 2 reports (14.29%)
  3. Red Blood Cell Count Decreased — 2 reports (14.29%)
  4. Urinary Tract Infection — 2 reports (14.29%)
  5. Abdominal Wall Abscess — 1 report (7.14%)
  6. Abnormal Loss Of Weight — 1 report (7.14%)
  7. Aplastic Anaemia — 1 report (7.14%)
  8. Asthenia — 1 report (7.14%)
  9. Autoimmune Anaemia — 1 report (7.14%)
  10. Bacteraemia — 1 report (7.14%)

Source database →

IV antibiotic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is IV antibiotic approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for IV antibiotic in United States?

Minia University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.